Phio Pharmaceuticals (PHIO) Market Capitalization (2012 - 2026)

Phio Pharmaceuticals (PHIO) has reported Market Capitalization for 15 consecutive years, with $11.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 5.09% year-over-year to $11.8 million; the trailing twelve-month figure through Jun 2026 stood at $11.8 million (up 5.09% YoY), and the FY2025 full-year result was $6.3 million, up 343.28% from the prior year.
• Market Capitalization retreated to $11.8 million in Q2 2026 per PHIO's latest filing, from $14.2 million in the prior quarter.
• Across five years, Market Capitalization topped out at $14.3 million in Q3 2025 and bottomed at $1.4 million in Q4 2024.
• Historically, Market Capitalization has averaged $7.1 million across 5 years, with a median of $6.2 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Market Capitalization plunged 71.59% in 2022, then soared 343.28% in 2025.
• Over 5 years, Market Capitalization stood at $5.1 million in 2022, then slumped by 68.86% to $1.6 million in 2023, then declined by 10.49% to $1.4 million in 2024, then soared by 343.28% to $6.3 million in 2025, then soared by 88.59% to $11.8 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $11.8 million, $14.2 million, and $6.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.